K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 376 JPY 0.3% Market Closed
Market Cap: 165.7B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note

Kaken Pharmaceutical Co Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kaken Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
K
Kaken Pharmaceutical Co Ltd
TSE:4521
EPS (Diluted)
ÂĄ191
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-2%
Takeda Pharmaceutical Co Ltd
TSE:4502
EPS (Diluted)
ÂĄ94
CAGR 3-Years
-30%
CAGR 5-Years
18%
CAGR 10-Years
-3%
Daiichi Sankyo Co Ltd
TSE:4568
EPS (Diluted)
ÂĄ119
CAGR 3-Years
43%
CAGR 5-Years
16%
CAGR 10-Years
2%
Otsuka Holdings Co Ltd
TSE:4578
EPS (Diluted)
ÂĄ233
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-2%
Chugai Pharmaceutical Co Ltd
TSE:4519
EPS (Diluted)
ÂĄ235
CAGR 3-Years
15%
CAGR 5-Years
23%
CAGR 10-Years
9%
Astellas Pharma Inc
TSE:4503
EPS (Diluted)
ÂĄ30
CAGR 3-Years
-18%
CAGR 5-Years
-24%
CAGR 10-Years
-4%

See Also

What is Kaken Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
191.9 JPY

Based on the financial report for Jun 30, 2024, Kaken Pharmaceutical Co Ltd's EPS (Diluted) amounts to 191.9 JPY.

What is Kaken Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-2%

Over the last year, the EPS (Diluted) growth was 43%. The average annual EPS (Diluted) growth rates for Kaken Pharmaceutical Co Ltd have been -17% over the past three years , -16% over the past five years , and -2% over the past ten years .

Back to Top